Asymptomatic Cerebrovascular Disease in Dialysis Patients

Area of Science:

• Neurology
• Nephrology
• Vascular Medicine

Background:

• Cerebrovascular disease significantly increases mortality in dialysis patients, with a higher stroke incidence than the general population.
• Asymptomatic cerebral small-vessel disease (CSVD), encompassing silent brain infarction (SBI), white matter hyperintensities (WMHs), and cerebral microbleeds (CMBs), is increasingly recognized as a predictor of future stroke.
• CSVD pathogenesis involves microvascular damage from conditions like arteriolosclerosis, fibrinoid necrosis, and lipohyalinosis, often exacerbated by advanced age and hypertension.

Purpose of the Study:

• To highlight the elevated prevalence of CSVD in dialysis patients.
• To underscore the association between CSVD markers and stroke risk in this population.
• To emphasize the need for further research into CSVD to inform stroke prevention strategies for dialysis patients.

Main Methods:

• Review of recent studies on cerebrovascular disease in dialysis patients.
• Analysis of the relationship between asymptomatic CSVD markers (SBI, WMHs, CMBs) and stroke incidence.
• Examination of the pathophysiological mechanisms underlying CSVD in the context of microvascular damage.

Main Results:

• Dialysis patients exhibit a substantially higher incidence of stroke compared to the non-dialysis population.
• Asymptomatic CSVD, including SBI, WMHs, and CMBs, is demonstrably linked to an increased risk of future stroke.
• Pathological mechanisms for SBI, WMHs, and CMBs involve vascular occlusion, fragility, and chronic ischemia, respectively.

Conclusions:

• Cerebral small-vessel disease is a critical factor contributing to stroke risk in dialysis patients.
• The high prevalence of CSVD in this cohort necessitates focused attention for stroke prevention.
• Accumulating evidence on CSVD in dialysis patients is crucial for developing effective preventative measures against stroke.